Registered Nurse in Summerdale, AL Accepting Medicare
1 Registered Nurse nurses found. Showing 1 - 1
 Alexandra Miller, CBS, RN Registered Nurse - Lactation Consultant Medicare: Not Enrolled in Medicare Practice Location: 17693 Dry Branch Rd, Summerdale, AL 36580 Phone: 251-978-0162 |
News Archive
New insect control method can bring decline in malaria-bearing mosquitoes
Research carried out in Mali, West Africa, has demonstrated that a new, safe and uncomplicated insect control method, developed at the Hebrew University of Jerusalem, can bring about a serious decline in malaria-bearing mosquitoes in afflicted regions in the world.
Outlaw teen sexuality!
That's right ban it, make it illegal, against the law, verboten. May is teen pregnancy prevention month. Let's get real about the problem that is confronting us. The United States now has more teen pregnancies than any other country in the industrialized world. Over 1 million teenagers get pregnant every year and 78% of teen pregnancies are unintended.
Generic erosion of premium-priced branded agents to offset sales of new agents
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that generic erosion of premium-priced branded agents will offset sales of new agents and will cause the acute coronary syndrome market for drugs in the hospital setting to decrease from $800 million in 2008 to $729 million in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Has COVID-19 vaccine confidence dropped following the pause of Johnson & Johnson/Janssen?
A new study, which was conducted by Vishala Mishra and Joseph P. Dexter at Madras Medical College, Chennai, India, suggests that the infamous pause in the administration of the Johnson & Johnson (J&J)/Janssen COVID-19 vaccine, advised by the FDA, has left doubt about the veracity of vaccine safety claims. This is a development that may have engendered vaccine hesitancy in a segment of the population.
Neutrolis announces development of first-in-class therapy to target NETs in COVID-19 patients
Neutrolis, a biotechnology company developing therapeutics that target neutrophils, the most abundant immune cells in the body, today announced the development of NTR-441, a first-in-class DNASE1L3 enzyme analog that has the potential to rapidly and systemically clear neutrophil extracellular traps for severe cases of COVID-19.
› Verified 3 days ago